These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7399411)

  • 1. Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.
    Zimmermann B; Damerau B; Vogt W
    Hoppe Seylers Z Physiol Chem; 1980; 361(6):915-24. PubMed ID: 7399411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum.
    Zimmermann B; Vogt W
    Hoppe Seylers Z Physiol Chem; 1984 Feb; 365(2):151-8. PubMed ID: 6714942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74.
    Gerard C; Showell HJ; Hoeprich PD; Hugli TE; Stimler NP
    J Biol Chem; 1985 Mar; 260(5):2613-6. PubMed ID: 3972798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
    Fernandez HN; Hugli TE
    J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
    Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    Fernandez HN; Hugli TE
    J Biol Chem; 1978 Oct; 253(19):6955-64. PubMed ID: 690134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically active complement (C5)-derived peptides and their relevance to disease.
    Perez HD
    Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human C5a des Arg increases vascular permeability.
    José PJ; Forrest MJ; Williams TJ
    J Immunol; 1981 Dec; 127(6):2376-80. PubMed ID: 6170701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization.
    Gerard C; Hugli TE
    J Biol Chem; 1979 Jul; 254(14):6346-51. PubMed ID: 447720
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
    Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
    J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE; Vallota EH; Müller-Eberhard HJ
    J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
    Kew RR; Webster RO
    J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.
    Perez HD; Goldstein IM; Webster RO; Henson PM
    J Immunol; 1981 Feb; 126(2):800-4. PubMed ID: 7451994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.